New drug combo tested to fight advanced throat cancer
NCT ID NCT03734809
Summary
This study is testing a new, year-long treatment plan for people with advanced nasopharyngeal cancer (a type of throat cancer). The plan combines an immunotherapy drug (pembrolizumab) with chemotherapy and radiation. The main goal is to see if this approach is safe and can better control the cancer and prevent it from spreading to other parts of the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NPC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
-
National Cancer Centre of Singapore
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.